Position in REGN
as of Mar 31, 2026
· filed Apr 13, 2026
Position Value
$1,134,235
-$18,938 QoQ
Shares Held
1,468
-1.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026IFP Advisors, Inc holds $42,046,886 across 205 Biotechnology names. REGN ranks #8 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AXSM |
Axsome Therapeutics, Inc.
|
60,994 | $10,309,205 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
39,148 | $7,400,929 | |
| 3 | TGTX |
Tg Therapeutics, Inc.
|
206,538 | $6,861,192 | |
| 4 | AUPH |
Aurinia Pharmaceuticals Inc.
|
327,791 | $4,857,862 | |
| 5 | VKTX |
Viking Therapeutics, Inc.
|
60,573 | $1,971,045 | |
| 6 | EXEL |
Exelixis, Inc.
|
43,450 | $1,863,570 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,720 | $1,214,588 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
1,468 | $1,134,235 |
All Filings in REGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,134,235 | 1,468 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $1,153,173 | 1,494 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $788,864 | 1,403 | Shares | Sole | 2026-02-06 | |
| 2025-06-30 | $645,750 | 1,230 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $649,451 | 1,024 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $262,137 | 368 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $330,089 | 314 | Shares | Sole | 2025-02-04 | |
| 2024-06-30 | $579,117 | 551 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $486,057 | 505 | Shares | Sole | 2024-07-30 | |
| 2023-12-31 | $429,483 | 489 | Shares | Sole | 2024-01-09 | |
| 2023-09-30 | $363,748 | 442 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $289,571 | 403 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $294,979 | 359 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $793,639 | 1,100 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $1,062,926 | 1,543 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $874,281 | 1,479 | Shares | Sole | 2022-09-06 | |
| 2022-03-31 | $1,032,963 | 1,479 | Shares | Sole | 2022-09-06 | |
| 2021-12-31 | $284,815 | 451 | Shares | Sole | 2022-01-12 | |
| 2021-09-30 | $315,298 | 521 | Shares | Sole | 2021-10-06 | |
| 2021-06-30 | $282,062 | 505 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $143,361 | 303 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $130,922 | 271 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $101,320 | 181 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $101,031 | 162 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $86,427 | 177 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||